Association between VEGF Receptors and Baseline Peritoneal Transport Status in New Peritoneal Dialysis Patients

REFERENCES

• Churchill DN, Thorpe KE, Nolph KD, . Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998;9:1285–1292.
   PubMed Web of Science ®Google Scholar
• Wang T, Heimburger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant. 1998;13(5):1242–1249.
   PubMed Web of Science ®Google Scholar
• Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol. 2006;17(1):271–278.
   PubMed Web of Science ®Google Scholar
• Stefanini MO, Wu FT, Mac Gabhann F, . The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol. 2009;5(12):e1000622.
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Tilton RG, Stephan CC, . Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol. 2001;12(8):1734–1741.
   PubMed Web of Science ®Google Scholar
• van Esch S, Zweers MM, Jansen MA, . Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int. 2004;24(6):554–561.
   PubMed Web of Science ®Google Scholar
• Rodrigues AS, Martins M, Korevaar IC, . Evaluation of peritoneal transport and membrane status in peritoneal dialysis: Focus on incident fast transporters. Am J Nephrol. 2007;27(1):84–91.
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, . Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13(1):9–22.
   PubMed Web of Science ®Google Scholar
• Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int. 2003;23(2):116–122.
   PubMed Web of Science ®Google Scholar
• Yang WS, Tsai TJ, Shih CL, . Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration. Blood Purif. 2009;28(1):69–74.
   PubMed Web of Science ®Google Scholar
• Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells Mol Dis. 2007;38(3):258–268.
   PubMed Web of Science ®Google Scholar
• Inoue M, Itoh H, Ueda M, . Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98(20):2108–2116.
   PubMed Web of Science ®Google Scholar
• Brogi E, Schatteman G, Wu T, . Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest. 1996;97(2):469–476.
   PubMed Web of Science ®Google Scholar
• Witmer AN, Blamwgeers HG, Weich HA. Alter expression patterns of VEGF-receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci. 2002;43:849–857.
   PubMed Web of Science ®Google Scholar
• Mints M, Blomgren B, Falconer C, . Expression of the vascular endothelial growth factor (VEGF) family in human endometrial blood vessels. Scand J Clin Lab Invest. 2002;62(3):167–175.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Seto K, Shinoda Y, . Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed hep G2 cells. Am J Physiol. 1999;276(1):G92–G97.
   PubMedGoogle Scholar
• Fong GH, Rossant J, Gertsenstein M, . Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376(6535):66–70.
   PubMed Web of Science ®Google Scholar
• Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 2001;276(29):26969–26979.
   PubMed Web of Science ®Google Scholar
• Zeng H, Zhao D, Mukhopadhyay D. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. J Biol Chem. 2002;277(6):4003–4009.
   PubMed Web of Science ®Google Scholar
• Eriksson U, Alitalo K. VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies. Nat Med. 2002;8(8):775–777.
   PubMed Web of Science ®Google Scholar
• Sawano A, Takahashi T, Yamaguchi S, . Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 1996;7(2):213–221.
   PubMedGoogle Scholar
• Kanno S, Oda N, Abe M, . Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene. 2000;19(17):2138–2146.
   PubMed Web of Science ®Google Scholar
• Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 2006;39(5):469–478.
   PubMedGoogle Scholar
• Shalaby F, Rossant J, Yamaguchi TP, . Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376(6535):62–66.
   PubMed Web of Science ®Google Scholar
• Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004;25(4):581–611.
   PubMed Web of Science ®Google Scholar
• Ewan LC, Jopling HM, Jia H, . Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic. 2006;7(9):1270–1282.
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci. 2001;114(Pt 5):853–865.
   PubMed Web of Science ®Google Scholar
• Baffert F, Thurston G, Rochon-Duck M, . Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res. 2004;94(7):984–992.
   PubMed Web of Science ®Google Scholar
• Kamba T, Tam BY, Hashizume H, . VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006;290(2):H560–H576.
   PubMed Web of Science ®Google Scholar
• Baffert F, Le T, Sennino B, . Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol. 2006;290(2): H547–H559.
   PubMed Web of Science ®Google Scholar
• Murohara T, Horowitz JR, Silver M, . Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998;97(1):99–107.
   PubMed Web of Science ®Google Scholar
• Gille H, Kowalski J, Li B, . Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001;276(5): 3222–3230.
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Kang-Decker N, Hughes DA, . Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 2005;19(12):1692–1694.
   PubMedGoogle Scholar